Advertisement

Topics

Innovus Pharmaceuticals Reports Nine Month Net Revenue of $6.4 million and Net Loss Decrease of 51.6% Compared to the Same Period in 2016

16:05 EST 14 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Quarterly and Year-to-Date Net Revenue Increase 18.0% and 105.8% When Compared to 2016 FlutiCare™ Launches on November 14, 2017 Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) ...

Other Sources for this Article

Emerging Markets Consulting, LLC
James S. Painter, III, (407) 340-0226
jamespainter@emergingmarketsllc.com

NEXT ARTICLE

More From BioPortfolio on "Innovus Pharmaceuticals Reports Nine Month Net Revenue of $6.4 million and Net Loss Decrease of 51.6% Compared to the Same Period in 2016"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...